Evidence-based·Updated November 16, 2026·How we grade evidence

Paroxetine

MedicationSSRI antidepressant (prescription)

Paroxetine is an established SSRI. A large network meta-analysis found it more effective than placebo for adult depression, and placebo-controlled trials support it for social anxiety disorder, PTSD and, at a low 7.5 mg dose, menopausal hot flashes. A reanalysis of a trial in adolescents found no benefit and more harms. St. John's wort is the critical supplement interaction; cannabis is a high-severity concern and saffron a low one.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Adults with depression, OCD, panic disorder, social anxiety disorder, generalized anxiety disorder or PTSD whose prescriber recommends an SSRI, and postmenopausal women with moderate to severe hot flashes (low-dose Brisdelle)

Common dosing range

Set by your prescriber. The Paxil label starts at 20 mg once daily for depression, OCD, social anxiety and PTSD, 10 mg for panic disorder and generalized anxiety disorder, with maximums of 50 to 60 mg a day depending on the condition; older adults and people with severe kidney or liver impairment start at 10 mg with a 40 mg maximum. Brisdelle is 7.5 mg once daily

When to expect effects

Depression trials in the network meta-analysis were acute trials of weeks; social anxiety and PTSD trials lasted 11 to 12 weeks; hot flashes fell by week 4

Watch out for

Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Never combine with MAO inhibitors or St. John's wort without your prescriber. Raises bleeding risk with aspirin, NSAIDs and blood thinners. First-trimester use is linked to a less than 2-fold rise in heart defects. Do not stop suddenly: the label recommends a gradual reduction

What is it

Paroxetine is a prescription antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, sold as generic tablets, Paxil tablets and Paxil CR extended-release tablets. The Paxil label approves it in adults for major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder and posttraumatic stress disorder. A low-dose capsule, Brisdelle (paroxetine mesylate 7.5 mg), is approved only for moderate to severe hot flashes of menopause, not for any psychiatric condition. Paroxetine is not approved for children. Its boxed warning covers suicidal thoughts and behaviors in young people. St. John's wort is the critical supplement interaction, cannabis a high-severity one and saffron a low-severity one.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have depression, OCD, panic disorder, social anxiety disorder, generalized anxiety disorder or PTSD and your prescriber recommends an SSRI (with a prescriber)
You are postmenopausal with moderate to severe hot flashes and your prescriber recommends low-dose paroxetine (with a prescriber)
You can keep follow-up visits to watch mood and side effects, especially early on and after dose changes, and you will review every supplement with your doctor or pharmacist

Probably skip if…

You take an MAO inhibitor or stopped one in the last 14 days, or take a QT-prolonging drug that is cleared by CYP2D6 (contraindicated)
You take tamoxifen for breast cancer: the label says prescribers should consider an antidepressant with little or no CYP2D6 blocking
You are planning a pregnancy or are in the first trimester: the label says to start it only after considering other options
You want to keep taking St. John's wort or other serotonin-boosting supplements without telling your prescriber
You are under 18: paroxetine is not approved for children, and pediatric depression trials did not show benefit

Evidence at a glance

major depressive disorder in adults

Good Evidence
Effect
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Time
Acute treatment trials lasting weeks

social anxiety disorder

Good Evidence
Effect
Large; about 31 more responders per 100 people than placebo
Best fit
Adults with the generalized type of social anxiety disorder
Time
Measured at the end of 11 weeks of active treatment

posttraumatic stress disorder (PTSD)

Good Evidence
Effect
Statistically significant improvement over placebo at 20 and 40 mg a day; the abstract does not give the size
Best fit
Adults with chronic PTSD
Time
Measured over 12 weeks

menopausal hot flashes (low-dose 7.5 mg)

Good Evidence
Effect
Modest; significant reductions in frequency versus placebo (exact sizes not in the abstract)
Best fit
Postmenopausal women with moderate to severe hot flashes who cannot or prefer not to use hormones
Time
By week 4

major depression in adolescents

Good Evidence
Effect
None; 1.6 points more improvement than placebo, not significant, with more harms
Best fit
Not applicable: no benefit was found in adolescents
Time
Measured at 8 weeks

Evidence for 5 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

major depressive disorder in adults

Disease adjunct
Good Evidence

A 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied, including paroxetine, were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, paroxetine was among the drugs that were more effective than other antidepressants. The authors rated the certainty of evidence moderate to very low. People with bipolar, psychotic or treatment-resistant depression were largely excluded.

Effect size
Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
Time to effect
Acute treatment trials lasting weeks
Best fit
Adults with major depressive disorder, without bipolar or psychotic features
Less likely
Children and teens, people with bipolar or psychotic depression, who were excluded

Bottom line: Paroxetine works better than placebo for adult depression and did well in head-to-head comparisons.

social anxiety disorder

Disease adjunct
Good Evidence

In a 12-week randomized, double-blind trial at 14 centers in the US and Canada, 187 adults with generalized social phobia received paroxetine (20 to 50 mg a day) or placebo. At the end, 55.0% on paroxetine were much or very much improved versus 23.9% on placebo, and Liebowitz Social Anxiety Scale scores fell by 39.1% versus 17.4%. The trial was short and did not test long-term use.

Effect size
Large; about 31 more responders per 100 people than placebo
Time to effect
Measured at the end of 11 weeks of active treatment
Best fit
Adults with the generalized type of social anxiety disorder
Less likely
People needing evidence beyond 12 weeks, which this trial did not provide

Bottom line: Paroxetine roughly doubled the share of people with social anxiety who improved over 11 weeks.

posttraumatic stress disorder (PTSD)

Disease adjunct
Good Evidence

In a 12-week fixed-dose trial, 551 outpatients with chronic PTSD were randomized to placebo, paroxetine 20 mg or paroxetine 40 mg a day. Both doses improved the main PTSD scale and global improvement more than placebo, and helped all three symptom clusters (re-experiencing, avoidance and numbing, and hyperarousal), social and work impairment, and depression. Benefit did not vary by sex, trauma type, time since trauma or baseline severity, and both doses were well tolerated.

Effect size
Statistically significant improvement over placebo at 20 and 40 mg a day; the abstract does not give the size
Time to effect
Measured over 12 weeks
Best fit
Adults with chronic PTSD
Less likely
People needing long-term data, which this 12-week trial did not provide

Bottom line: Paroxetine 20 or 40 mg a day eased chronic PTSD symptoms more than placebo over 12 weeks.

menopausal hot flashes (low-dose 7.5 mg)

Disease adjunct
Good Evidence

Two multicenter, double-blind trials lasting 12 and 24 weeks randomized 1,184 postmenopausal women with moderate to severe hot flashes to paroxetine 7.5 mg once daily or placebo. In both trials paroxetine reduced the weekly number of hot flashes more than placebo at week 4 and week 12, and the benefit persisted through 24 weeks. Severity also fell more in most comparisons. Most side effects were mild or moderate. This low dose is the Brisdelle product, not the doses used for depression.

Effect size
Modest; significant reductions in frequency versus placebo (exact sizes not in the abstract)
Time to effect
By week 4
Best fit
Postmenopausal women with moderate to severe hot flashes who cannot or prefer not to use hormones
Less likely
Women taking tamoxifen, for whom the label advises an alternative because of reduced tamoxifen effect

Bottom line: Low-dose paroxetine reduced menopausal hot flashes more than placebo in two large trials.

major depression in adolescents

No benefit found
Good Evidence

A 2015 reanalysis of the full data from Study 329, an 8-week randomized trial in 275 adolescents with major depression at 12 North American centers, found paroxetine (20 to 40 mg a day) no better than placebo on any prespecified primary or secondary outcome: Hamilton depression scores fell by 10.7 points with paroxetine and 9.1 with placebo. It found clinically significant increases in harms with paroxetine, including suicidal thinking and behavior. The current Paxil label states that effectiveness in pediatric depression was not shown in three placebo-controlled trials.

Effect size
None; 1.6 points more improvement than placebo, not significant, with more harms
Time to effect
Measured at 8 weeks
Best fit
Not applicable: no benefit was found in adolescents
Less likely
Adolescents with major depression, in whom no benefit was shown

Bottom line: Paroxetine did not help depressed adolescents in Study 329 and increased harms; it is not approved for children.

How it works

Paroxetine blocks the reuptake of serotonin in the brain, so this chemical messenger stays active longer. It is also a strong blocker of the liver enzyme CYP2D6, which it partly relies on for its own clearance; because that pathway saturates, blood levels rise more than expected as the dose goes up. The label gives a mean half-life of about 21 hours, and steady levels are reached in about 10 days for most people. These features shape its interactions. Products that also raise serotonin, such as St. John's wort, tryptophan, triptans, tramadol and other antidepressants, raise the risk of serotonin syndrome, and MAO inhibitors are contraindicated. Drugs that affect serotonin reuptake make bleeding more likely, which matters with aspirin, NSAID pain relievers and blood thinners. And by blocking CYP2D6, paroxetine raises levels of other drugs cleared by that enzyme and can weaken tamoxifen, which needs CYP2D6 to form its active metabolite.

How to take it

1. Typical dose
Your prescriber sets the dose. The Paxil label gives these adult starting and maximum daily doses: depression 20 mg (maximum 50 mg); OCD 20 mg (maximum 60 mg); panic disorder 10 mg (maximum 60 mg); PTSD 20 mg (maximum 50 mg); social anxiety disorder 20 mg (maximum 60 mg); generalized anxiety disorder 10 mg for one week, then 20 mg (maximum 50 mg). Increases are made in steps of 10 mg a day at weekly intervals if needed. Older adults and people with severe kidney or severe liver impairment start at 10 mg a day, with a maximum of 40 mg a day. Before starting, the label calls for screening for a personal or family history of bipolar disorder. Brisdelle, for menopausal hot flashes, is 7.5 mg once daily.
2. Higher studied dose
The label maximum is 60 mg a day for OCD, panic disorder and social anxiety disorder. For social anxiety disorder and generalized anxiety disorder, the label says available information does not suggest added benefit above 20 mg a day.
3. Timing
Once daily in the morning, as the Paxil label directs; Brisdelle is taken once daily at bedtime
4. With food
The label says it can be taken with or without food. Food raised the peak level by 29% but overall exposure by only 6%.
5. Split dosing
Not split; once daily
6. How long to try
Your prescriber decides how long. When stopping, the label recommends a gradual dose reduction rather than abrupt stopping whenever possible; in generalized anxiety disorder and PTSD trials the dose was lowered by 10 mg a day each week, ending with a week at 20 mg. At least 14 days must pass between stopping paroxetine and starting an MAO inhibitor, and the reverse.

What to track

Mood changes, new or worse depression, anxiety, agitation or suicidal thoughts, especially in the first months and after dose changes (contact your provider right away)
Agitation, sweating, fast heartbeat, tremor, fever or diarrhea, which can signal serotonin syndrome (seek urgent care)
Unusual bruising or bleeding, especially if you also take aspirin, NSAIDs or a blood thinner
Headache, confusion, weakness or unsteadiness, which can signal low sodium, particularly in older adults or people on diuretics
Dizziness, irritability, nausea or electric-shock sensations after a missed dose or dose reduction
Changes in sexual function, which you can raise with your prescriber

Bottom line: Your prescriber sets the dose; take it once daily in the morning, keep serotonin-boosting supplements out unless your prescriber agrees, and never stop suddenly on your own.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, dry mouth, constipation, diarrhea and decreased appetiteSleepiness, or trouble sleeping and nervousnessWeakness, dizziness, tremor and yawningSweatingSexual problems: abnormal ejaculation, erectile problems, lower libido and female genital disorders

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: the Paxil label says paroxetine can cause fetal harm. First-trimester exposure is associated with a less than 2-fold increase in cardiovascular malformations, so for women planning a pregnancy or in the first trimester it should be started only after considering other treatment options. SSRI exposure, particularly in the month before delivery, is associated with a less than 2-fold higher risk of heavy bleeding after birth, later exposure with persistent pulmonary hypertension of the newborn, and babies exposed late in the third trimester have needed prolonged hospital care, breathing support or tube feeding. Women who stop antidepressants during pregnancy are more likely to relapse, so the risks of untreated depression also count. A pregnancy registry for antidepressants collects outcomes. Breastfeeding: paroxetine passes into breast milk (relative infant doses of 0.4% to 2.2%), and there are reports of agitation, irritability, poor feeding and poor weight gain in exposed infants. The label says to weigh the benefits of breastfeeding against the mother's need for treatment and to monitor the infant for these signs.

Interactions

St. John's wort (Hypericum perforatum)Critical

The Paxil label lists St. John's wort among serotonergic products that increase the risk of serotonin syndrome, a potentially life-threatening reaction, when combined with paroxetine, and a systematic review of St. John's wort interactions identified possible serotonin-related interactions with SSRIs. Do not combine them unless your prescriber advises it, check mood-support teas and blends for Hypericum, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness. Do not stop paroxetine on your own.

L-tryptophanCritical

The Paxil label says combining paroxetine with tryptophan, the amino acid the body turns into serotonin, increases the risk of serotonin syndrome, a potentially life-threatening reaction, and the label for Brisdelle (low-dose paroxetine) says headache, nausea, sweating and dizziness have been reported when tryptophan was given with paroxetine and that the combination is not recommended. No serotonin syndrome case with this exact pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

5-HTP (5-hydroxytryptophan)Critical

5-HTP is the body's direct building block for serotonin, so it adds to paroxetine's serotonin effect. The Paxil label names tryptophan, the amino acid the body turns into 5-HTP, among products that increase the risk of serotonin syndrome; it does not name 5-HTP itself, and no paroxetine case has been published. Do not combine them unless your prescriber directs it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.

MAO inhibitors (such as phenelzine, tranylcypromine, selegiline, linezolid, intravenous methylene blue)Critical

Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days between stopping an MAOI and starting paroxetine, and at least 14 days after stopping paroxetine before starting an MAOI.

Cannabis (THC and CBD products)High

A published case report describes a 20-year-old man taking fluoxetine (another SSRI) and lithium who had repeated episodes of serotonin syndrome needing hospital care, twice within hours of using high-THC cannabis oil or a vape pen. In lab studies, CBD and THC blocked CYP2D6, one of the enzymes that clears paroxetine, so they could raise paroxetine levels, though this has not been tested in people. Tell your prescriber about any cannabis or CBD use, and treat agitation, tremor, sweating, fever or a racing heart after use as an emergency.

Aspirin, NSAIDs (ibuprofen, naproxen), warfarin and other blood thinnersHigh

Paroxetine increases the risk of bleeding, and the label says aspirin, NSAIDs, other antiplatelet drugs, warfarin and other anticoagulants may add to this risk. People on warfarin need closer clotting tests (INR) when paroxetine is started, changed or stopped. Ask your pharmacist before using an over-the-counter pain reliever.

TamoxifenHigh

The label says paroxetine blocks CYP2D6 irreversibly, lowering the level of tamoxifen's active metabolite (endoxifen). Some studies found lower tamoxifen effectiveness against breast cancer relapse and death with paroxetine, though others did not, and the label says prescribers should consider an antidepressant with little or no CYP2D6 blocking. Make sure your oncologist and prescriber both know you take these medicines.

Saffron (supplements)Low

Saffron may act partly through serotonin, which raises a theoretical concern about added serotonin effects. In a placebo-controlled trial of 160 adults already taking an antidepressant, adding a standardized saffron extract (14 mg twice daily) for 8 weeks improved clinician-rated depression scores without increasing antidepressant side effects, though self-rated scores improved no more than with placebo. Paroxetine was not studied separately. Discuss it with your prescriber before adding saffron.

Documented interactions

Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.

Warnings (3)

+ 5-htp

critical

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Paxil label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with paroxetine and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.

+ st. john's wort

critical

Paroxetine is an SSRI that raises serotonin by blocking its reuptake. St. John's wort independently raises serotonin and also speeds up drug-metabolizing enzymes and P-glycoprotein. Taken together, the additive serotonin effect can precipitate serotonin syndrome, a potentially life-threatening reaction, and the paroxetine label lists St. John's Wort among the drugs that raise this risk.

+ tryptophan

critical

Paroxetine is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Paxil label says combining paroxetine with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. The label for Brisdelle, a low-dose paroxetine, adds that headache, nausea, sweating and dizziness have been reported when tryptophan was given to people taking paroxetine and says the combination is not recommended. No published case of serotonin syndrome with this exact pair was found; the rating follows the labels and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.

See all 3 Paroxetine interactions →

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Generic paroxetine, Paxil or Paxil CR dispensed by a licensed pharmacy on your own prescription
Paxil tablets come in 10, 20, 30 and 40 mg; Paxil CR is an extended-release tablet; Brisdelle 7.5 mg capsules are only for menopausal hot flashes
A Medication Guide with each fill, which explains the suicidality warning
Once-daily morning dosing, with or without food

Be skeptical of…

Mood or "serotonin support" supplements containing St. John's wort presented as safe with antidepressants
Products claiming to be a natural replacement for paroxetine, or advice to switch to herbs and stop the medicine
Online sellers offering paroxetine without a prescription
Advice to stop quickly or skip doses to reduce side effects

Frequently asked questions

Can I take St. John's wort with paroxetine?⌄

This page rates it a critical interaction. The Paxil label lists St. John's wort among products that raise the risk of serotonin syndrome with paroxetine. Talk to your prescriber before using it, and if you have been combining them, contact your prescriber rather than stopping anything on your own.

Is it safe to use cannabis or CBD while taking Paxil?⌄

Tell your prescriber about any use. A case report linked high-THC cannabis to repeated serotonin syndrome in a man taking another SSRI, and in lab studies CBD and THC blocked CYP2D6, an enzyme that clears paroxetine. This page rates the pair high.

Can I take saffron supplements with paroxetine?⌄

The concern is theoretical. Saffron may act partly on serotonin, but in a trial of adults already on antidepressants it did not increase side effects. This page rates the pair low severity. Ask your prescriber before starting it.

Can I take ibuprofen or aspirin with paroxetine?⌄

Ask your pharmacist or prescriber first. The label says aspirin and NSAIDs such as ibuprofen and naproxen add to paroxetine's bleeding risk, as do warfarin and other blood thinners.

What happens if I stop paroxetine suddenly?⌄

Stopping suddenly can cause discontinuation symptoms such as dizziness, irritability, nausea, sweating and electric-shock sensations. The label recommends a gradual reduction rather than abrupt stopping. Talk to your prescriber before making any change.

References by claim

major depressive disorder in adults

Cipriani et al., 2018 · PMC (2018) link

social anxiety disorder

Stein et al., 1998 · PubMed (1998) link

posttraumatic stress disorder (PTSD)

Marshall et al., 2001 · PubMed (2001) link

menopausal hot flashes (low-dose 7.5 mg)

Simon et al., 2013 · PubMed (2013) link

major depression in adolescents

Le Noury et al., 2015 · PMC (2015) link

Safety

Paxil (paroxetine) tablets prescribing information · DailyMed (FDA label) link

Interaction: St. John's wort (Hypericum perforatum)

Henderson et al., 2002 · PMC (2002) link

Interaction: L-tryptophan

Brisdelle (paroxetine) capsules prescribing information · DailyMed (FDA label) link

Interaction: 5-HTP (5-hydroxytryptophan)

Patel et al., 2017 · PMC (2017) link

Interaction: Cannabis (THC and CBD products)

Nadeem et al., 2024 · PMC (2024) link

Yamaori et al., 2011 · PubMed (2011) link

Interaction: Saffron (supplements)

Lopresti et al., 2019 · PubMed (2019) link

Lopresti et al., 2014 · PubMed (2014) link

Track Paroxetine with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 16, 2026·Evidence current as of Nov 16, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.